What is AOD-9604?

AOD-9604 is a research peptide in the Body Recomposition class. C-terminal fragment of hGH (176–191); investigated for lipolytic activity. It is studied at per-dose ranges of 300 mcg / day (1.5–2 mg weekly), administered daily sc (fasted) over cycles of 12 weeks on / 4 off. Supplied in Thailand by Thailand Peptides — Bangkok-based, research use only.

16-amino-acid fragment of hGH. Preclinical data suggests selective lipolysis without affecting IGF-1.

Published and preclinical data are summarised below; dose ranges shown reflect protocols in the research literature and should be interpreted accordingly.

How does AOD-9604 work?

Primary mechanism: C-terminal fragment of hGH (176–191); investigated for lipolytic activity. Research on AOD-9604 implicates downstream effects on related signalling cascades, with magnitude and clinical relevance dependent on dose, timing, and individual pharmacogenomic factors.

Receptor binding affinity and post-receptor signalling for AOD-9604 remain areas of active investigation; several proposed effects within the Body Recomposition class are currently supported only by in-vitro or rodent data, and should be interpreted accordingly.

AOD-9604 dosage & protocol

Reference protocol for AOD-9604 (research context only, drawn from published literature):

  • Per dose: 300 mcg / day
  • Weekly total: 1.5–2 mg
  • Frequency: Daily SC (fasted)
  • Cycle: 12 weeks on / 4 off

Stacking AOD-9604

Commonly referenced pairing with AOD-9604: GHRH analog. Stacking rationale should be grounded in complementary mechanisms, not additive speculation; interactions at shared receptors or enzymatic pathways should be accounted for. Both compounds in a AOD-9604 stack are supplied by Thailand Peptides on the same order via the Bangkok research desk.

Contraindications

Active malignancy. Additional caution is warranted in individuals with hepatic or renal impairment, endocrine disorders, or concurrent pharmacotherapy affecting the pathways described above.

AOD-9604 — common questions

What is AOD-9604 and what is it used for in research?
AOD-9604 is classified within the Body Recomposition group. 16-amino-acid fragment of hGH. Preclinical data suggests selective lipolysis without affecting IGF-1. Research applications focus on the pathways outlined below. All references on this page describe published research only — AOD-9604 is supplied for in-vitro and laboratory use, not for human consumption.
How does AOD-9604 work?
Primary mechanism: C-terminal fragment of hGH (176–191); investigated for lipolytic activity. Downstream effects depend on dose, timing, and the biological system under investigation. Receptor binding and post-receptor signalling for AOD-9604 remain areas of active study, and several proposed effects are supported only by preclinical data.
What is the typical AOD-9604 research dose?
Published research protocols for AOD-9604 describe per-dose ranges of 300 mcg / day, with a weekly total near 1.5–2 mg, administered daily sc (fasted). Typical cycle: 12 weeks on / 4 off. These ranges reflect the literature and are not dosing recommendations for any individual.
Where can I buy AOD-9604 in Thailand?
AOD-9604 is supplied by Thailand Peptides, a Bangkok-based research-peptide supplier. Orders are placed directly via WhatsApp to the Bangkok research desk — no cart, no account, no forms. Pricing and shipping are provided on request. Open a line with the research desk →
How fast can AOD-9604 be delivered in Thailand?
Same-week delivery across Thailand is standard for orders confirmed within business hours (GMT+7, Monday–Saturday). Bangkok metro deliveries typically arrive within 1–3 business days; other provinces within 3–5. Regional Southeast Asia shipping is available on request.

Citations

  1. Heffernan M, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice. Endocrinology. 2001. PMID: 11713213

References curated from PubMed. Additional literature summarised in the Thailand Peptides research library.